Home › Funds › CPP Investments › ABBV

CPP Investments position in ABBV

ABBVIE INC · Health Care

CPP Investments reported holding 3,271,028 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$855.7M, representing 0.47% of its reported portfolio and ranking #39 among its reported holdings. CPP Investments has disclosed ABBV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)3.27M sh
Reported value held$855.67M
Portfolio Weight0.47%
First reportedQ3 2021
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How CPP Investments's ABBV position evolved

CPP Investments first disclosed a stake in ABBV in Q3 2021 at 2,818,041 shares (US$304.0M). The position peaked in Q3 2026 at 3,271,028 shares, worth US$855.7M. Across 21 filings, CPP Investments increased the stake 10 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,271,028 shares valued at US$855.7M — an increase of 22,446 shares quarter over quarter.. Notable position changes include a 38% trim in Q1 2025 (shares fell 11% over the following quarter), a 43% increase in Q2 2025 (shares rose 26% over the following quarter), a 27% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 2.82M $303.98M New
Q4 2021 3.33M $450.85M Add
Q1 2022 2.94M $477.07M Reduce
Q2 2022 2.63M $403.01M Reduce
Q3 2022 2.23M $299.80M Reduce
Q4 2022 1.85M $299.56M Reduce
Q1 2023 1.83M $291.05M Reduce
Q2 2023 1.91M $257.57M Add
Q3 2023 2.28M $339.60M Add
Q4 2023 2.38M $369.04M Add
Q1 2024 2.34M $425.97M Reduce
Q2 2024 2.87M $492.07M Add
Q3 2024 2.98M $588.85M Add
Q4 2024 2.82M $501.87M Reduce
Q1 2025 1.75M $367.53M Reduce
Q2 2025 2.51M $466.58M Add
Q3 2025 3.19M $737.73M Add
Q4 2025 2.79M $637.86M Reduce
Q1 2026 2.65M $575.59M Reduce
Q2 2026 3.25M $817.47M Add
Q3 2026 3.27M $855.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has CPP Investments held ABBV?

CPP Investments has disclosed ABBV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is CPP Investments's current position in ABBV?

As of Q3 2026, CPP Investments holds 3.27M shares of ABBV (ABBVIE INC), valued at $855.67M, representing 0.47% of its reported portfolio and ranking #39.

Has CPP Investments been buying or selling ABBV?

In the latest 13F filing (Q3 2026), CPP Investments increased its position in ABBV. The position peaked in Q3 2026 at 3.27M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.